Stephen T. Lundy appointed Chief Executive Officer and President
Company: Riot
What the later record shows
Not a promise: a reported event · happened March 24, 2010
The claim, made on 2010-10-21, reports that Lundy was appointed CEO, President and director on March 24, 2010, an event that had already happened.
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Stephen T. Lundy was appointed to the positions of Chief Executive Officer and President effective March 24, 2010, and appointed to the Company's Board of Directors on the same date.
Source (primary)
Riot DEF 14A filed 2010-10-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “Stephen T. Lundy was appointed to the positions of Chief Executive Officer and President on March 24, 2010. Effective on the same date, he was appointed to the Company's Board of Directors.”
How we checked this
Checked on October 12, 2026. The cited source supports every part of this claim.
The proxy statement says Lundy became CEO and President on March 24, 2010 and joined the board effective the same date.
Confirmed in the source:
- Stephen T. Lundy was appointed Chief Executive Officer and President of AspenBio Pharma on March 24, 2010
- Lundy was appointed to AspenBio Pharma's Board of Directors effective the same date, March 24, 2010
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997310001118/appy_def14a.htm) in full (159,763 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot DEF 14A filed 2010-10-22
Quote: “Stephen T. Lundy was appointed to the positions of Chief Executive Officer and President on March 24, 2010. Effective on the same date, he was appointed to the Company's Board of Directors.”